Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population

Digestive Diseases and Sciences

Volumn 57, Issue 12, 2012, Pages 3258-3264

  Park, Seung Ha ^a   Heo, Nae Yun ^a   Park, Jong Ha ^a   Kim, Tae Oh ^a   Yang, Sung Yeun ^a   Kim, Hyun Kuk ^a   Moon, Young Soo ^a   Kim, Chang Hoon ^b   Suk, Ki Tae ^c   Kim, Dong Joon ^c   Lee, Heon Young ^d  

^a Inje University College of Medicine   (South Korea)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Hallym University College of Medicine   (South Korea)

^d Chungnam National University College of Medicine   (South Korea)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Screening; Survey

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; CANCER SCREENING; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ECHOGRAPHY; FEMALE; HEALTH SURVEY; HEPATITIS B; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; SEROPREVALENCE; SEX DIFFERENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MASS SCREENING; ODDS RATIO; REPUBLIC OF KOREA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84871630934     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2281-6     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.
3. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004;11:298-303.
4. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-422.
5. Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg. 1998;227:513-518.
6. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer. 1998;83:2302-2311.
7. The World Gastrointestinal Organization. WGO practice guideline - hepatocellular carcinoma (HCC): a global perspective [online]. Available at: http://www.worldgastroenterology.org/hepatocellular-carcinoma.html. Accessed 20 Jan 2012.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
9. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474.
10. Davila JA, Weston A, Smalley W, El-Serag HB. Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2007;41:777-782.
11. Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007;5:508-512.
12. Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154:85-93.
13. The Korean Association for Survey Research. Sampling design of the 4th (2007-2009) KNANES. Available at: http://knhanescdcgokr/. Accessed 20 Jan 2012.
14. The Korean Association for Survey Research. Weighting Adjustment of the 4th KNANES (2007-2009) and Sampling Design of the 5th (2010-2012) KNANES. Available at: http://knhanescdcgokr/. Accessed 20 Jan 2012.
15. National Cancer Control Institute. National Cancer Screening Program. Available at: http://www.ncc.re.kr/english/programs/progarms03.jsp. Accessed 20 Jan 2012.
16. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010;52:132-141.
17. Zaman SN, Johnson PJ, Williams R. Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas. Cancer. 1990;65:1607-1610.
18. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg. 1990;211:277-287.
19. Screening for chronic hepatitis B among Asian/Pacific Islander populations-New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:505-509.
20. Choe JH, Taylor VM, Yasui Y, et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health. 2006;8:193-201.
21. Taylor VM, Jackson JC, Chan N, Kuniyuki A, Yasui Y. Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington. J Community Health. 2002;27:151-163.
22. Park NH, Chung YH. Molecular mechanisms of hepatitis B virus-associated hepatocellular carcinoma. Korean J Hepatol. 2007;13:320-340.
23. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst. 2004;96:1851-1856.
24. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer. 2004;101:1009-1017.
25. Park SH, Kim CH, Kim DJ, et al. Prevalence of alcoholic liver disease among korean adults: results from the fourth Korea national health and nutrition examination survey, 2009. Subst Use Misuse. 2011;46:1755-1762.
26. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:748-757.